Weight Management Program for Adults With Obesity During Cancer Treatment
Tests a diet, home exercise and behavioral support program in adults with obesity and cancer.
Plain-language title generated from the registry record
Registry title: Weight Management in Obese Cancer Patients During Curative Active Treatment
Key facts
- Where
- L'Hospitalet de Llobregat, SpainSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with obesity and a newly diagnosed solid tumour (stage II-IV) who will have treatment meant to remove all of the disease. It tests a weight loss program.
- Age
- 18 years or older
- Sex
- All
- Disease stage
- Solid tumour confirmed by tissue examination, stage II-IV, with chemotherapy, radiotherapy or both planned, meant to remove all of the disease. Expected treatment time of 3 months or more.
- Earlier treatment
- Cannot be in another weight loss program. Cannot have had weight loss (bariatric or LapBand) surgery or be waiting for it.
- Biomarker or test result
- BMI of 30 kg/m² or higher. ECOG performance status of 0-1.
Main reasons for not taking part
- Melanoma or brain tumour
- Surgery as the only treatment
- Tumour sites with high risk of malnutrition, such as head and neck, upper digestive tract or pancreas
- Pregnancy or breastfeeding, or another active cancer
- Conditions that prevent unsupervised exercise, or a pacemaker or other implanted electrical device
Read by machine on 12 November 2026.
Where in Spain
- Institut Català d'Oncologia. Catalan Institute of OncologyL'Hospitalet de Llobregat, SpainContact: Lorena ArribasTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Institut d'Investigació Biomèdica de Bellvitge
- Trial code
- NCT07058207
- Record updated
- 12 November 2026
- Original description
This is a feasibility study intervention to fifty cancer patients with obesity and with newly diagnosed stage II-IV solid tumors undergoing curative treatment recruited at the Catalan Institute of Oncology (ICO) in L'Hospitalet, Spain.Read full original descriptionShow less
Weight Management in Obese Cancer Patients During Curative Active Treatment (CANOBESE Study): A Feasibility Study
This is a feasibility study intervention to fifty cancer patients with obesity and with newly diagnosed stage II-IV solid tumors undergoing curative treatment recruited at the Catalan Institute of Oncology (ICO) in L'Hospitalet, Spain.
The investigators hypothesize that weight management during cancer treatment could enhance health outcomes for this population. The feasibility of a multimodal weight loss management program will be assesses, including a personalized hypocaloric and high-protein diet combined with a supervised exercise home-program and behavioural support.
Inclusion: Adult (age 18+) with pathologically confirmed malignant solid tumors, stage II-IV, elected for oncological treatment (chemo, radio, or both) with curative intend; Expected oncological treatment time ≥ 3 months; BMI ≥ 30 kg/m²; Resident in the Barcelona area up to the completion of cancer treatment; ECOG Perfomance Status (PS) 0-1; Availability of internet access.
Exclusion: Surgery as the only treatment; History of bariatric (or LapBand) surgery, or considering or currently on a wait-list for bariatric or LapBand surgery; Patients with any concurrent medical or psychological condition that, in the investigator's opinion, would jeopardize the safety of the patient or compliance with the protocol; Tumour localizations with high risk of malnutrition (such as head and neck, upper gastrointestinal tract, or pancreatic cancer):; Another active malignancy; Current health or medical condition that affects weight status, e.g., untreated hyper- or hypothyroidism,etc; Pre-existing medical condition that precludes adherence to unsupervised exercise, e.g., severe orthopedic conditions, scheduled for a hip or knee replacement, bone metastases, paralysis, dementia, untreated stage 3 hypertension, or unstable angina, heart attack, congestive heart failure or conditions that dictated hospitalization or oxygen within 6-months; Active suicidal ideation, anorexia, bulimia, binge eating disorder, current substance abuse or dependence (besides nicotine dependence); Patients with melanoma and brain tumours; Pregnancy or breastfeeding; Unable to read or understand Spanish or Catalan; Enrolled in a weight loss program; Use of pacemaker or another electrical implanted device.